News & Blog
News & Blog
Lexeo Therapeutics Announces Progress in FDA Discussions for Accelerated Approval Pathway and Positive Interim Clinical Data for LX2006 in Friedreich Ataxia Cardiomyopathy
September/October 2025 – Advocacy Newsletter
Meet the Community: Casey Kasselder
2025 Fall for FARA Recap
Larimar Therapeutics Announces Positive Data from Ongoing Long-term Open Label Study and Updates to Nomlabofusp Program for Friedreich’s Ataxia
Meet the Community: Anna Helmig
Meet the Community: Donna Littell
Webinar Recording: Solid Biosciences September 2025 Update
Siblings Jake and Claire Juip face Friedreich’s ataxia together
2025 FA Swing for a Cure Tournament Recap
